The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides: evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts. New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings are also available. The Medical Letter also provides comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
